NorthWest Biotherapeutics Inc (NWBO)

[john1045]

Northwest Biotherapeutics Inc. (NWBO) Jumps 7.82% on October 30 -

See more at: http://www.equities.com/editors-desk/stocks/market-movers/northwest-biotherapeutics-inc-nwbo-jumps-on-october-30#sthash.ExPIEUqR.dpuf

Northwest Biotherapeutics Inc. (NWBO) was among the biggest gainers on the Russell 2000 for October 30 as the stock popped 7.82% to $5.38, representing a gain of $0.39 per share. Some 857,480 shares traded hands on 3,191 trades, compared with an average daily volume of 550,271 shares out of a total float of 59,504,996. The stock opened at $5.04 and traded with an intraday range of $4.97 to $5.45. After today's gains, Northwest Biotherapeutics Inc. reached a market cap of $320,136,878. Northwest Biotherapeutics Inc. has had a trading range between $10.64 and $3.10 over the last year, and it had a 50-day SMA of $5.25 and a 200-day SMA of $6.07.

Northwest Biotherapeutics Inc is a development stage biotechnology company engaged in the development of immunotherapy products to treat cancers more effectively than current treatments, without toxicities of the kind associated with chemotherapies. Northwest Biotherapeutics Inc. is based out of Bethesda, MD and has some 12 employees. It's CEO is Linda F Powers.

For a full analysis of Northwest Biotherapeutics Inc., check out Equities.com's E.V.A. report. The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index. Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole. -

See more at: http://www.equities.com/editors-desk/stocks/market-movers/northwest-biotherapeutics-inc-nwbo-jumps-on-october-30#sthash.ExPIEUqR.dpuf